Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancerTommaso Susini, Simonetta Bianchi, Ketty Tavella et al.|OncoTargets and Therapy|2014Cited by 13